1. Design and evaluation of a multi-epitope DNA vaccine against HPV16.
- Author
-
Zhu L, Cui X, Yan Z, Tao Y, Shi L, Zhang X, Yao Y, and Shi L
- Subjects
- Female, Animals, Papillomavirus E7 Proteins immunology, Mice, Humans, T-Lymphocytes, Cytotoxic immunology, Repressor Proteins immunology, T-Lymphocytes, Helper-Inducer immunology, Mice, Inbred C57BL, Interferon-gamma metabolism, Interferon-gamma immunology, Papillomavirus Vaccines immunology, Papillomavirus Vaccines administration & dosage, Human papillomavirus 16 immunology, Vaccines, DNA immunology, Vaccines, DNA administration & dosage, Papillomavirus Infections prevention & control, Papillomavirus Infections immunology, Epitopes, T-Lymphocyte immunology, Oncogene Proteins, Viral immunology, Oncogene Proteins, Viral genetics, Uterine Cervical Neoplasms prevention & control, Uterine Cervical Neoplasms immunology, Uterine Cervical Neoplasms virology
- Abstract
Cervical cancer, among the deadliest cancers affecting women globally, primarily arises from persistent infection with high-risk human papillomavirus (HPV). To effectively combat persistent infection and prevent the progression of precancerous lesions into malignancy, a therapeutic HPV vaccine is under development. This study utilized an immunoinformatics approach to predict epitopes of cytotoxic T lymphocytes (CTLs) and helper T lymphocytes (HTLs) using the E6 and E7 oncoproteins of the HPV16 strain as target antigens. Subsequently, through meticulous selection of T-cell epitopes and other necessary elements, a multi-epitope vaccine was constructed, exhibiting good immunogenic, physicochemical, and structural characteristics. Furthermore, in silico simulations showed that the vaccine not only interacted well with toll-like receptors (TLR2/TLR3/TLR4), but also induced a strong innate and adaptive immune response characterized by elevated Th1-type cytokines, such as interferon-gamma (IFN-γ) and interleukin-2 (IL2). Additionally, our study investigated the effects of different immunization intervals on immune responses, aiming to optimize a time-efficient immunization program. In animal model experiments, the vaccine exhibited robust immunogenic, therapeutic, and prophylactic effects. Administered thrice, it consistently induced the expansion of specific CD4 and CD8 T cells, resulting in substantial cytokines release and increased proliferation of memory T cell subsets in splenic cells. Overall, our findings support the potential of this multi-epitope vaccine in combating HPV16 infection and signify its candidacy for future HPV vaccine development.
- Published
- 2024
- Full Text
- View/download PDF